oldid29793

Terapia takeover complete

Advent Central&Eastern Europe II investment fund, managed by US company Advent International, acquired about 90.7% of Romanian drugmaker Terapia Cluj during the public takeover bid run on the Bucharest Exchange, according to sources close to the transaction